Cited by 492Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research AdvancesMetabolism and Genetic Disorders

Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results

Eisenhofer, Graeme, Goldstein, David S., Walther, McClellan M., Friberg, Peter, Lenders, Jacques W. M., Keiser, Harry R., Pacak, Karel·2003·The Journal of Clinical Endocrinology & Metabolism

Abstract

Measurements of plasma normetanephrine and metanephrine provide a highly sensitive test for diagnosis of pheochromocytoma, but false-positive results remain a problem. We therefore assessed medication-associated false-positive results and use of supplementary tests, including plasma normetanephrine responses to clonidine, to distinguish true- from false-positive results. The study included 208 patients with pheochromocytoma and 648 patients in whom pheochromocytoma was excluded. Clonidine-suppression tests were carried out in 48 patients with and 49 patients without the tumor. Tricyclic antidepressants and phenoxybenzamine accounted for 41% of false-positive elevations of plasma normetanephrine and 44-45% those of plasma and urinary norepinephrine. High plasma normetanephrine to norepinephrine or metanephrine to epinephrine ratios were strongly predictive of pheochromocytoma. Lack of decrease and elevated plasma levels of norepinephrine or normetanephrine after clonidine also confirmed pheochromocytoma with high specificity. However, 16 of 48 patients with pheochromocytoma had normal levels or decreases of norepinephrine after clonidine. In contrast, plasma normetanephrine remained elevated in all but 2 patients, indicating more reliable diagnosis using normetanephrine than norepinephrine responses to clonidine. Thus, in patients with suspected pheochromocytoma and positive biochemical results, false-positive elevations due to medications should first be eliminated. Patterns of biochemical test results and responses of plasma normetanephrine to clonidine can then help distinguish true- from false-positive results.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2002-030005

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., & Pacak, K.
Affiliations
  • National Institutes of Health (US)
  • National Institute of Neurological Disorders and Stroke (US)
  • National Cancer Institute (US)
  • Sahlgrenska University Hospital (SE)
  • Radboud University Medical Center (NL)
  • National Heart, Lung, and Blood Institute (US)
Corresponding author
Eisenhofer, Graeme
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-06
Volume
88
Issue
6
Pages
2656-2666
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2109611875
Cited by
492
References
48
Citations by year
2026: 12 · 2025: 9 · 2024: 18 · 2023: 20 · 2022: 25 · 2021: 22 · 2020: 24 · 2019: 23 · 2018: 16 · 2017: 29 · 2016: 16 · 2015: 23 · 2014: 33 · 2013: 21 · 2012: 23
FWCI
16.94
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
pheochromocytoma, false positives, metanephrine, clonidine suppression test, norepinephrine, tricyclic antidepressants, phenoxybenzamine, diagnostic specificity, epinephrine
MeSH terms
Adrenal Gland Neoplasms, Adrenergic alpha-Antagonists, Adult, Antidepressive Agents, Tricyclic, Biochemistry, Clonidine, Drug Interactions, False Positive Reactions, Female, Humans, Male, Middle Aged, Norepinephrine, Normetanephrine, Phenoxybenzamine, Pheochromocytoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review